Inventor · disambiguated record
Qi Shuai
Also filed as: SHUAI QI
18 granted patents·5 pending applications·128 citations·filing 2004–2015
92Inventor score
Top patents by PatentIndex Score
23 records- 0194US7217838B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBOTT LAB·Filed 2006·Granted May 15, 2007·26 cites·27 claims
- 0292US8648069B25-substituted indazoles as kinase inhibitorsAKRITOPOULOU-ZANZE IRINI·Filed 2008·Granted Feb 11, 2014·44 cites·7 claims
- 0391US7511175B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBOTT LAB·Filed 2006·Granted Mar 31, 2009·18 cites·15 claims
- 0489US7880001B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzymeABBOTT LAB·Filed 2005·Granted Feb 1, 2011·9 cites·31 claims
- 0587US7855308B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzymeABBOTT LAB·Filed 2009·Granted Dec 21, 2010·9 cites·35 claims
- 0685US7528282B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBOTT LAB·Filed 2007·Granted May 5, 2009·7 cites·36 claims
- 0784US9163007B25-substituted indazoles as kinase inhibitorsABBVIE INC·Filed 2013·Granted Oct 20, 2015·8 cites·6 claims
- 0878US7671076B2Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)ABBOTT LAB·Filed 2008·Granted Mar 2, 2010·3 cites·19 claims
- 0977US7348346B2Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)ABBOTT LAB·Filed 2005·Granted Mar 25, 2008·3 cites·2 claims
- 1072US8415354B2Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeBITNER R SCOTT·Filed 2009·Granted Apr 9, 2013·1 cites·2 claims
- 1162US2009192198A1Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBOTT LAB·Filed 2009·Application pending·0 cites
- 1261US8198331B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeBITNER R SCOTT·Filed 2009·Granted Jun 12, 2012·0 cites·10 claims
- 1360US2010152179A9Treatment of central nervous system disordersABBOTT LAB·Filed 2008·Application pending·0 cites
- 1458US9464072B2Treatment of central nervous system disordersABBVIE INC·Filed 2014·Granted Oct 11, 2016·0 cites·11 claims
- 1556US9290444B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBVIE INC·Filed 2014·Granted Mar 22, 2016·0 cites·6 claims
- 1656US9133145B2Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBVIE INC·Filed 2013·Granted Sep 15, 2015·0 cites·19 claims
- 1754US8716345B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeBITNER R SCOTT·Filed 2012·Granted May 6, 2014·0 cites·9 claims
- 1852US8940902B2Treatment of central nervous system disordersBITNER R SCOTT·Filed 2012·Granted Jan 27, 2015·0 cites·1 claims
- 1951US8993632B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeBITNER R SCOTT·Filed 2012·Granted Mar 31, 2015·0 cites·18 claims
- 2045US2015265613A1Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBVIE INC·Filed 2015·Application pending·0 cites
- 2143US8314270B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeLINK JAMES T·Filed 2010·Granted Nov 20, 2012·0 cites·6 claims
- 2241US2005245534A1Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzymeLINK JAMES T·Filed 2004·Application pending·0 cites
- 2340US2005215603A1Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)AKRITOPOULOU-ZANZE IRINI·Filed 2004·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →